¼¼°èÀÇ ´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, ¿öÅ©Ç÷ο캰, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÎ¹® ¿¹Ãø(2024-2030³â)
Single-cell Analysis Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Application (Cancer, Stem Cell), By Workflow (Downstream Analysis, Data Analysis), By End-use, By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1493254
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

¼¼°èÀÇ ´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå ±Ô¸ð´Â 2030³â¿¡ 136¾ï 9,000¸¸ ´Þ·¯·Î Ãß°èµÇ¾î 2024³âºÎÅÍ 2030³â¿¡ °ÉÃÄ CAGR 18.7%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

±â¼úÀÇ Áøº¸, ¾Ï ¿¬±¸¿¡ À־ÀÇ ¿ëµµÀÇ È®´ë, ¼¼Æ÷ ±â¹ÝÀÇ ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎ º¸Á¶±Ý Áõ°¡°¡ ½ÃÀåÀÇ ÁÖµÈ ÃËÁø¿äÀÎÀÔ´Ï´Ù. °Ô´Ù°¡ COVID-19 ÆÒµ¥¹ÍÀÇ °á°ú·Î ½ÃÀåÀÌ ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 1¿ù, American Journal of Physiology¿¡ µû¸£¸é, COVID-19 °¨¿° ȯÀÚÀÇ ¸»ÃÊ Ç÷¾× ´ÜÇÙ ¼¼Æ÷ ÇÁ·ÎÆÄÀÏÀÇ º¯È­´Â Áú·® ¼¼Æ÷ °èÃø¹ý¿¡ ÀÇÇÑ ´ÜÀÏ ¼¼Æ÷ ºÐ¼®(SEA)À» »ç¿ëÇÏ¿© Á¶»çµÇ¾úÀ¸¸ç, ÀÌ´Â ¾÷°è ¼ºÀå ¸¦ º¸ÃæÇß½À´Ï´Ù.

ÇöÀç ÁøÇà ÁßÀÎ À¯ÇàÀÇ °æÁ¦Àû¡¤»çȸÀû ºñ¿ë¿¡ ´ëÀÀÇϱâ À§ÇØ ¼¼°è Á¤ºÎ ±â°üÀÌ ¹é½Å °³¹ß¡¤Á¦Á¶¸¦ À§ÇÑ ÀÚ±ÝÀ» Áõ¾×Çϰí ÀÖÀ¸¸ç COVID-19 ¿¬±¸¸¦ À§ÇÑ SEA ÅøÀÇ »ç¿ëÀÌ Áõ°¡ Çϰí ÀÖ½À´Ï´Ù. ´õ ³ªÀº ¿¹ÈÄ ¹× Áø´Ü ÁöÇ¥¸¦ °³¹ßÇÏ°í ½É°¢ÇÑ º´Å¸¦ ³ªÅ¸³»´Â »ç¶÷µé¿¡ ´ëÇÑ ÀûÀýÇÑ Ä¡·á Á¢±Ù¹ýÀ» ¼ö¸³Çϱâ À§Çؼ­´Â º´¿ø¼ºÀ» ÅëÇÑ ¼÷ÁÖÀÇ ¸é¿ª ¹ÝÀÀÀ» ¾Æ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù. µû¶ó¼­ COVID-19´Â ´ÜÀÏ ¼¼Æ÷ ºÐ¼®ÀÌ Áúº´ÀÇ ¸»ÃÊ ¸é¿ª ±â´ÉÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀ̵ǰí Áúº´ÀÇ º´Å »ý¸®ÇÐ ¹× Ä¡·á °¡´É¼º¿¡ ´ëÇÑ ¿¬±¸¿¡ »õ·Î¿î ±â¿©¸¦Çϱ⠶§¹®¿¡ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.

´ÜÀÏ ¼¼Æ÷ ±â¼úÀº °æ·Î¿Í °úÁ¤ÀÇ ºÐÀÚ ¼öÁØÀ» °Ë»çÇÏ°í ¼¼Æ÷ÀÇ ÀÌÁú¼ºÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ ±â¼úÀº Á¾¾çÇÐ, ¸é¿ªÇÐ ¹× ±âŸ ºÐ¾ß¿¡¼­ ºü¸£°Ô ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡, transcriptome°ú proteome °úÁ¤À» º¸´Ù ´Ü¼øÈ­ÇÏ´Â Á¤±³ÇÑ ÅøÀÇ °³¹ßÀÌ SEA¹ýÀÇ »ç¿ëÀ» µÞ¹ÞħÇϰí ÀÖ½À ´Ï´Ù. ¿¬±¸ÀÚµéÀº ÇöÀç scRNA ½ÃÄö½Ì(scRNAseq)ÀÇ ¹ßÀü¿¡ ÀÇÇØ ÀÌÀü¿¡ ¿¬±¸µÇÁö ¾Ê¾Ò´ø ºñ-ÀϹÝÀûÀÎ ¼¼Æ÷ À¯ÇüÀ» Á¾ÇÕÀûÀ¸·Î Á¶»çÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¹ÙÀÌ¿À¸ÞµðÄà ºÐ¾ß¿¡¼­ ´ÜÀÏ ¼¼¸£°Ô³ð/Æ®·£½ºÅ©¸³Æ® ºÐ¼®ÀÇ ÀÀ¿ëÀº ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ±â¼úÀÇ ¹ßÀü¿¡ ÀÇÇØ Å©°Ô È®»êµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ¼¼Æ÷ÀÇ ÇØ¸®¿Í Á¶Á÷ÀÇ ¼ÒÈ­´Â ´Ù¾çÇÑ ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ÀåÄ¡¿¡ ÀûÀÀÇϰí, SEA ±â¼úÀÇ Ã¤¿ëÀ» Áõ°¡½Ã۰í, ¾÷°èÀÇ ¼ºÀåÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

ÀÌ ºÐ¾ß¿¡¼­ R&D¿¡ ´ëÇÑ ÅõÀÚ È帧 Áõ°¡´Â ¿¬±¸ ¹ßÇ¥ ¼ö Áõ°¡¿¡µµ ¹Ý¿µµË´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 4¿ù¿¡´Â º¥Ã³ ijÇÇÅ»ÀÇ i&i Biotech Fund°¡ À¯ÀüÀÚ º¯Çü ¼¼Æ÷¸¦ »ç¿ëÇÏ¿© ȯ°æ ³»ÀÇ ´Ù¸¥ ¼¼Æ÷¸¦ °Ë»çÇÏ´Â Áø´Ü Ç÷§ÆûÀ» °³¹ßÇÑ ÀþÀº »ý¸í °úÇÐ ±â¼úÀÇ ½ÅÈï ±â¾÷ Sampling Human¿¡ 200¸¸ ´Þ·¯ÀÇ ÀÚ±ÝÀ» Á¦°øÇß½À´Ï´Ù(i&i Bio). °Ô´Ù°¡ R&D¿Í »ç¾÷ÀÇ ¼ºÀåÀº ¸ðµÎ ÀÌ ÅõÀÚ¿¡ ÀÇÇØ ÃËÁøµË´Ï´Ù. °Ô´Ù°¡ R&D ³ë·ÂÀº Çõ½ÅÀÇ ±âÃʰ¡ µÇ±â ¶§¹®¿¡ ÀÌ·¯ÇÑ ÁöÃâÀº ÀÌ ½ÃÀåÀÇ ´õ ³ªÀº ¼ºÀå ±âȸ¸¦ º¸¿©ÁÝ´Ï´Ù. °Ô´Ù°¡ °úÇÐÀÚµéÀº À¯ÀüÀÚ ¹ßÇö ÇÁ·ÎÆÄÀÏÀÇ Áö¿ª º¯µ¿À» ´ÜÀÏ ¼¿ ¼öÁØ¿¡¼­ ºÐ¼®Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ºÐ¼®À» À§ÇÑ ¼Ò¸ðǰ°ú Àåºñ ¼ö¿ä¸¦ Áõ°¡½ÃŰ°í ¾÷°è ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå : Á¦Ç° ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦5Àå ´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå : ¿ëµµÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦6Àå ´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå : ¿öÅ©Ç÷οìÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦7Àå ´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå : ÃÖÁ¾ ¿ëµµÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦8Àå ´ÜÀϼ¼Æ÷ ºÐ¼® ½ÃÀå : Á¦Ç°, ¿ëµµ, ¿öÅ©Ç÷οì, ÃÖÁ¾ ¿ëµµº° Áö¿ª ÃßÁ¤ ¹× µ¿Ç⠺м®.

Á¦9Àå °æÀï ±¸µµ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Single-cell Analysis Market Growth & Trends:

The global single-cell analysis market size was estimated at USD 13.69 billion in 2030 and is projected to grow at a CAGR of 18.7% from 2024 to 2030. Technology advances, expanding applications in cancer research, and higher government funding for cell-based research are the main drivers of the market. In addition, the market is advancing as a result of the COVID-19 pandemic. For instance, in January 2021, according to the American Journal of Physiology, variations in the peripheral blood mononuclear cellular profiles of COVID-19-infected patients were examined by using single-cell analysis (SEA) through mass cytometry, which supplemented the industry growth.

Government agencies around the world have increased funding for vaccine development and production in response to the ongoing pandemic's economic and social costs, which has increased the use of SEA tools for COVID-19 research. In order to develop better prognostic and diagnostic indicators and establish suitable therapeutic approaches for people with serious disease presentation, it is essential to know the host immune response throughout pathogenicity. Therefore, the market is positively impacted by COVID-19 because single-cell analysis helps in the assessment of peripheral immune function in the disease and makes new contributions to the study of the disease's pathophysiology and treatment possibilities.

Single-cell technology aids in the molecular level examination of pathways and processes as well as the assessment of cellular heterogeneity. This technology is developing rapidly with uses in oncology, immunology, and other fields. Further, the development of sophisticated tools that make transcriptomic and proteomic processes simpler is boosting the use of SEA methods. Researchers are now able to comprehensively examine previously unstudied uncommon cell types owing to developments in scRNA sequencing (scRNAseq). The application of single-cell genomic/transcriptomic analysis in the biomedical area has been greatly expanded by the development of microfluidics technology. Furthermore, cell dissociation and tissue digestion have been adapted for a large range of microfluidic devices, which have increased the adoption of SEA technology and further boosted industry growth.

The rising investment flow in R&D in this space is reflected in the rising number of research publications. For instance, in April 2020, A USD 2 million funding round was headed by the venture capital firm i&i Biotech Fund for Sampling Human, a young life science technology startup that has created a diagnostic platform that uses genetically modified cells to examine other cells in their environment (i&i Bio). Further, R&D and business growth will all be advanced by the investment. Moreover, these expenditures indicate a better growth opportunity for this market because R&D efforts serve as the foundation for innovation. Additionally, scientists are analyzing geographic variability in gene expression profiles at the single-cell level, which is expected to increase the demand for consumables and equipment for analysis, thus propelling the industry's growth.

Single-cell Analysis Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Single-cell Analysis Market Variables, Trends & Scope

Chapter 4. Single-cell Analysis Market: Product Estimates & Trend Analysis

Chapter 5. Single-cell Analysis Market: Application Estimates & Trend Analysis

Chapter 6. Single-cell Analysis Market: Workflow Estimates & Trend Analysis

Chapter 7. Single-cell Analysis Market: End-Use Estimates & Trend Analysis

Chapter 8. Single-cell Analysis Market: Regional Estimates & Trend Analysis By Product, Application, Workflow & End-use.

Chapter 9. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â